The clinical profile, genetic basis and survival of childhood cardiomyopathy: a single-center retrospective study

被引:1
|
作者
Yuan, Wenjing [1 ]
Jia, Zhongli [1 ]
Li, Jiajin [1 ]
Liu, Lingjuan [1 ]
Tian, Jie [1 ]
Huang, Xupei [2 ]
Quan, Junjun [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders,Natl Clin, Dept Cardiol,China Int Sci & Technol Cooperat Base, Childrens Hosp,Minist Educ,Key Lab Child Dev & Dis, 136 Zhongshan Er Rd, Chongqing 400014, Peoples R China
[2] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL USA
基金
中国国家自然科学基金;
关键词
Cardiomyopathy; Children; Clinical characteristics; Outcome; Risk factor; SUDDEN CARDIAC DEATH; PEDIATRIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CHILDREN; OUTCOMES; NONCOMPACTION; EPIDEMIOLOGY; PROGNOSIS;
D O I
10.1007/s00431-023-05358-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cardiomyopathy (CM) is a heterogeneous group of myocardial diseases in children. This study aimed to identify demographic features, clinical presentation and prognosis of children with CM. Clinical characteristics and prognostic factors associated with mortality were evaluated by Cox proportional hazards regression analyses. Genetic testing was also conducted on a portion of patients. Among the 317 patients, 40.1%, 25.2%, 24.6% and 10.1% were diagnosed with dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), left ventricular noncompaction cardiomyopathy (LVNC) and restrictive cardiomyopathy (RCM), respectively. The most common symptom observed was dyspnea (84.2%). Except for HCM, the majority of patients were classified as NYHA/Ross class III or IV. The five-year survival rates were 75.5%, 67.3%, 74.1% and 51.1% in DCM, HCM, LVNC and RCM, respectively. The ten-year survival rates were 60.1%, 56.1%, 57.2% and 41.3% in DCM, HCM, LVNC and RCM, respectively. Survival was inversely related to NYHA/Ross class III or IV in patients with DCM, HCM and RCM. Out of 42 patients, 32 were reported to carry gene mutations.Conclusions: This study demonstrates that CM, especially RCM, is related to a high incidence of death. NYHA/Ross class III or IV is a predictor of mortality in the patients and gene mutations may be a common cause.Trial registration: MR-50-23-011798.What is Known:center dot Cardiomyopathy (CM) is a heterogeneous group of myocardial diseases and one of the leading causes of heart failure in children due to the lack of effective treatments.center dot There remains scarce data on Asian pediatric populations though emerging studies have assessed the clinical characteristics and outcomes of CM.What is New:center dot A retrospective study was conducted and the follow-up records were established to investigate the clinical characteristics, the profile of gene mutations and prognostic outcomes of children with CM in Western China.center dot CM, especially RCM, is related to a high incidence of death. NYHA/Ross class III or IV is a predictor of mortality in the patients and gene mutations may be a common cause.
引用
收藏
页码:1389 / 1401
页数:13
相关论文
共 50 条
  • [1] The clinical profile, genetic basis and survival of childhood cardiomyopathy: a single-center retrospective study
    Wenjing Yuan
    Zhongli Jia
    Jiajin Li
    Lingjuan Liu
    Jie Tian
    Xupei Huang
    Junjun Quan
    European Journal of Pediatrics, 2024, 183 : 1389 - 1401
  • [2] Clinical and Genetic Profile of Chinese Children With Danon Disease: A Single-Center Retrospective Cohort Study
    Zhang, Qingni
    Chan, Wenxiu
    Chen, Yiwei
    Wu, Jinjin
    Chen, Hao
    Yu, Tingting
    Yao, Ruen
    Chen, Lijun
    Zhang, Bing
    Zhang, Hao
    Zhang, Zhen
    Fu, Lijun
    CANADIAN JOURNAL OF CARDIOLOGY, 2025, 41 (01) : 89 - 101
  • [3] Clinical profile and outcomes of childhood dilated cardiomyopathy - A single-center three-decade experience
    Mukhtar, Gousia
    Sasidharan, Bijulal
    Krishnamoorthy, Kavassery Mahadevan
    Kurup, Harikrishnan K. N.
    Gopalakrishnan, Arun
    Sasikumar, Deepa
    Sarma, Sankara
    Valaparambil, Ajit Kumar
    Sivasubramonian, Sivasankaran
    ANNALS OF PEDIATRIC CARDIOLOGY, 2023, 16 (03) : 175 - 181
  • [4] Molecular and clinical profile of rare bleeding disorders: A single-center retrospective study
    Moghadam, Arash Ahmadfard
    Manafzadeh, Amir Reza
    Nikoonia, Mohammad Reza
    Dajliry, Khadijeh
    Ramezan, Farahnaz
    Tabibian, Shadi
    TRANSFUSION AND APHERESIS SCIENCE, 2024, 63 (03)
  • [5] Clinical Characteristics and Outcomes of Dilated Cardiomyopathy in Chinese Children: A Single-Center Retrospective Study
    Chen, Cheng
    Huang, Yanyun
    Su, Danyan
    Qin, Suyuan
    Ye, Bingbing
    Huang, Yuqin
    Liu, Dongli
    Pang, Yusheng
    CHILDREN-BASEL, 2024, 11 (08):
  • [6] Hypertrophic Cardiomyopathy in the Era of Genetics: A Single-Center Retrospective Study
    Sadaf, Humaira
    Buja, L. Maximilian
    LABORATORY INVESTIGATION, 2024, 104 (03) : S354 - S355
  • [7] Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China
    Wang, Shuai
    Peng, Wenke
    Pang, Min
    Mao, Ling
    Peng, Daoquan
    Yu, Bilian
    Wu, Sha
    Hu, Die
    Yang, Yang
    He, Jia
    Ouyang, Mingqi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Clinical and genetic features of childhood-onset congenital combined pituitary hormone deficiency: a retrospective, single-center cohort study
    Lee, Yoonha
    Lee, Young Ah
    Ko, Jung Min
    Shin, Choong Ho
    Lee, Yun Jeong
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 29 (06) : 379 - 386
  • [9] Differences in clinical features of hypertrophic cardiomyopathy with or without left ventricular enlargement: a single-center and retrospective study
    Ou, B. Baiqing
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 363 - 364
  • [10] Clinical profile and survival of patients with lupus nephritis in the department of nephrology in Cameroon: a single-center study
    Ebana, Hermine Danielle Fouda Menye
    Mahamat, Maimouna
    Lekpa, Fernando Kemta
    Jemmy, Caroline Kenmegne
    Ashuntantang, Gloria
    Halle, Marie-Patrice
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41